# ALSA Ventures

> ALSA Ventures is a VC fund in London backing Biotechnology and Therapeutics. See 6 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: London, United Kingdom
- Total investments: 6
- Last investment: May 2025
- Lead investor: 0%
- Last updated: Aug 2026
- Website: https://www.alsaventures.com/

ALSA Ventures is a London based international life science investor focused on novel therapeutics.

## Contacts

5 contacts available for ALSA Ventures. Shizune tracks 1 team members at ALSA Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/alsa-ventures?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series B | $16M–$41M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 4 | 67% |
| Therapeutics | 3 | 50% |
| Life Science | 2 | 33% |
| Apps | 1 | 17% |
| Genetics | 1 | 17% |

16 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 33% |
| Series A | 2 | 33% |
| Series B | 1 | 17% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United Kingdom | 2 | 33% |
| Belgium | 1 | 17% |
| Bangladesh | 1 | 17% |
| Switzerland | 1 | 17% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Graeme Martin | Chief Investment Officer | 11 | https://shizune.co/investors/profile/graeme-martin |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| ReproNovo | ReproNovo is providing patients all over the world with significant improvement by developing cutting-edge therapeutic solutions for uterine disorders including adenomyosis and for male and female infertility. | $65M | Series A | May 21, 2025 |  |
| Epsilogen | IGEM Therapeutics is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.The company's offerings include IgE-based drugs targeting solid tumors, enabling patients to kill parasites which reside in human tissue, also the home of the solid tumor. | $16.3M | Series B | Sep 09, 2024 |  |
| Jatri | Jatri is the fastest growing technology company in Bangladesh with a mission to bring reliable transport to everyone, everywhere at the touch of a button. We are offering a mobility-as-a-service platform that enhances bus system reliability and quality. |  | Series A | Apr 15, 2023 |  |
| Epsilogen | IGEM Therapeutics is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.The company's offerings include IgE-based drugs targeting solid tumors, enabling patients to kill parasites which reside in human tissue, also the home of the solid tumor. | $41.2M | Series B | Mar 02, 2022 |  |
| Promatix | Promatix is a biotechnology company. They develop a pipeline of novel therapeutics. They identify and validate novel drug targets at a protein level using TxPro. |  | Seed | Mar 08, 2021 |  |
| Montis Biosciences | Montis Biosciences is develops novel immune-oncology therapeutics targeting the intersection between vascular dysfunction and immune suppression to treat solid tumours. | $9.1M | Seed | Feb 20, 2020 |  |

6 of 6 investments shown.

## Co-investors
- [Novartis Venture Fund](https://shizune.co/investors/profile/novartis-venture-fund) — VC Fund, 3 deals together
- [British Patient Capital](https://shizune.co/investors/profile/british-patient-capital) — VC Fund, 2 deals together
- [Epidarex Capital](https://shizune.co/investors/profile/epidarex-capital) — VC Fund, 2 deals together
- [3B Future Health Fund](https://shizune.co/investors/profile/helsinn-investment-fund) — VC Fund, 2 deals together
- [AXA Alternative Investments](https://shizune.co/investors/profile/axa-im-alts) — VC Fund, 1 deal together
- [Brain-Too-Free Ventures](https://shizune.co/investors/profile/brain-too-free-ventures) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [SV Angel](https://shizune.co/investors/profile/sv-angel) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [SBK](https://shizune.co/investors/profile/sbk-tech-ventures) — VC Fund
- [Orbit Ventures](https://shizune.co/investors/profile/orbit-ventures) — VC Fund
- [Bangladesh Angels](https://shizune.co/investors/profile/bangladesh-angels) — VC Fund

## Featured in investor lists
- [Media (entertainment) VC Funds in Bangladesh](https://shizune.co/investors/media-entertainment-vc-funds-bangladesh)
- [Transportation VC Funds in Bangladesh](https://shizune.co/investors/transportation-vc-funds-bangladesh)
- [Software Investors in Bangladesh](https://shizune.co/investors/software-investors-bangladesh)
- [Enterprise VC Funds in Bangladesh](https://shizune.co/investors/enterprise-vc-funds-bangladesh)
- [SaaS Investors in Bangladesh](https://shizune.co/investors/saas-investors-bangladesh)
- [SaaS VC Funds in Bangladesh](https://shizune.co/investors/saas-vc-funds-bangladesh)

## FAQ

### What does ALSA Ventures invest in?

ALSA Ventures invests primarily in Biotechnology, Therapeutics and Life Science startups, most often at Seed and Series A stage. Most of the 6 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is ALSA Ventures's check size?

ALSA Ventures typically joins rounds of $16M–$41M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds ALSA Ventures participates in.

### How do I contact ALSA Ventures?

Public channels for ALSA Ventures include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at ALSA Ventures?

The team at ALSA Ventures includes Graeme Martin (Chief Investment Officer). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co